Abstract:Objective. To investigate the risk factors of axillary lymph node metastasis in patients with invasive breast cancer. Methods. This study retrospectively included 122 cases of invasive breast cancer patients admitted to the First Medical Center of PLA General Hospital from January 2019 to September 2020. According to postoperative pathological results, axillary lymph node metastasis was divided into axillary lymph node metastasis (ALNM) group ( n =40) and non-axillary lymph node metastasis (NALNM) group ( n =82). General demographic information was collected and compared between the two groups. Collected pathological results included lymphovascular invasion (LVI) and the expression of estrogen receptor (ER), progestogen receptor (PR), human epidermal growth factor receptor 2 (HER-2), and Ki-67 detected by immunohistochemistry. Imaging parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) including apparent diffusion coefficient (ADC), early enhanced rate, and time-intensity curve (TIC) were also included into univariate analysis. The variables with differences between the two groups were compared by univariate analysis, and the related factors of axillary lymph node metastasis were analyzed by logistic regression model. Results. There was no significant difference in general demographic information between the two groups. No significant differences were found in the positive rates of HER-2, ER, PR, Ki-67, pathological types, and clavicular lymph node metastasis and skin chest wall invasion between the two groups ( P > 0.05 ). The proportion of LVI in ALNM group was significantly higher than that in NALNM group (37.50% vs. 6.10%, P < 0.001 ). The proportion of breast cancer on the left side in the ALNM group was higher than that in the NALNM group, and the difference was statistically significant (70.00% vs. 47.56%, P = 0.019 ). There were no significant differences in the imaging parameters obtained by DCE-MRI between the two groups. Binary logistics regression analysis showed that LVI (OR =12.258, 95% CI =3.681-40.812, P < 0.001 ) and left breast cancer (OR =3.598, 95% CI =1.404-9.219, P = 0.008 ) were risk factors for axillary lymph node metastasis in patients with invasive breast cancer. Conclusion. The formation of vascular tumor thrombi in breast cancer tissue and left breast cancer are risk factors for axillary lymph node metastasis in invasive breast cancer and might be helpful for preoperative detailed assessment of the patient's condition.

A Multivariate Analysis of Clinicopathologic Factors in Lymphatic Metastasis of Breast Cancer

Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Molecular Biological Markers Expression in Breast Cancer and Its Relationship with Clinicopathological Features

Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer

Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer.

Analysis on related factors of axillary lymph node metastasis in patients with cT1-2 N0 breast cancer

Expression of ER, PR, CerbB-2, PS2, Cathepsin D and its relationship with the clinical pathology in premenopausal patients with breast canceR

Predictive value of ultrasonography and other multiple factors in breast cancer axillary lymph nodes metastasis

Correlation Analysis between Tumor Infiltrating Lymphocytes and Clinicopathological Characteristics and Prognosis of Breast Cancer under a Microscope

Prognostic Value Of Ki-67 In Breast Cancer Patients With Positive Axillary Lymph Nodes: A Retrospective Cohort Study

A Logistic Regression Model for Predicting Axillary Lymph Node Metastases in Early Breast Carcinoma Patients

Expression Correlation of Ki67 to P53,VEGF,and C-erbB-2 Genes in Breast Cancer and Their Clinical Significances

The Relation Between Expression of P16, P53, CDK4/cyclinD1 and Prognosis in Breast Cancer Cells

The Levels of Ki-67 Positive Are Positively Associated with Lymph Node Metastasis in Invasive Ductal Breast Cancer

Expression of C-Erbb-2,p53,pcna and Nm23 Proteins in Breast Cancer and Their Clinical Significance

Relationship between molecular typing and axillary lymph node metastasis in breast cancer patients with different T stages and its clinical significance

Analyses of prognostic factors for breast cancer patients

Prognostic value of Ki-67 in axillary lymph node-positive breast cancer after mastectomy

Analysis of Clinicopathologic Factors Correlating with Prognosis of 146 Cases of Breast Cancer

[Expression of molecular markers detected by immunohistochemistry and risk of lymph node metastasis in stage T1 and T2 colorecrectal cancers]